Risk factors associated with high-risk nodal disease in patients considered for active surveillance of papillary thyroid microcarcinoma without extrathyroidal extension

被引:5
作者
Kwon, Ohjoon [1 ]
Lee, Sohee [2 ]
Bae, Ja Seong [3 ]
机构
[1] Catholic Univ Korea, Dept Surg, Yeouido St Marys Hosp, Coll Med, Seoul 150713, South Korea
[2] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Surg, 1021 Tongil ro, Seoul 03312, South Korea
[3] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul St, Seoul, South Korea
关键词
Papillary thyroid carcinoma (PTC); thyroid cancer; active surveillance (AS); higher-risk N1; lymph node metastasis; PROGNOSTIC-SIGNIFICANCE; MANAGEMENT GUIDELINES; EXTRANODAL EXTENSION; LYMPH-NODES; METASTASIS; CARCINOMA; DISSECTION; RECURRENCE; NODULES; CANCER;
D O I
10.21037/gs-23-256
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Active surveillance (AS) has become an alternative treatment approach for papillary thyroid microcarcinoma (PTMC). The purpose of this study is to uncover the clinicopathological factors associated with high-risk nodal disease in order to select proper candidates for AS of PTMC.Methods: We retrospectively reviewed 5,329 patients with PTMC without extrathyroidal extension (ETE) who underwent thyroidectomy with central compartment neck dissection (CCND) between 2007 and 2021 at Seoul St. Mary's Hospital. Patients with more than five metastatic lymph nodes (MLNs) (higher-risk N1 disease) and/or lateral neck node metastases (N1b disease) were defined as having high-risk nodal disease. The clinicopathological factors associated with high-risk nodal disease were analyzed.Results: A total of 415 (7.8%) patients had higher-risk N1 disease. These patients were younger on average, included a higher proportion of males, and had a larger tumor size and more frequent capsular invasion and multifocality compared with other patients. For the tumor size, a cutoff value of 0.65 cm was the best predictor of nodal risk groups. In a multivariate analysis, the independent risk factors associated with higher-risk N1 disease were younger age, male sex, tumor size >0.65 cm, and the presence of capsular invasion and/or multifocality. A total of 246 (4.6%) patients had N1b disease at initial diagnosis. In a multivariate analysis, the independent risk factors associated with N1b disease were younger age, male sex, tumor size >0.65 cm, and the presence of capsular invasion and/or multifocality.Conclusions: Young age, male sex, tumor size >0.65 cm, and presence of capsular invasion and/or multifocality can be considered risk factors for high-risk nodal disease in PTMC. Therefore, cautious observation is necessary for AS of patients with these characteristics.
引用
收藏
页码:1179 / 1190
页数:12
相关论文
共 44 条
[1]   Diagnostic Test Accuracy of Ultrasonography vs Computed Tomography for Papillary Thyroid Cancer Cervical Lymph Node Metastasis A Systematic Review and Meta-analysis [J].
Alabousi, Mostafa ;
Alabousi, Abdullah ;
Adham, Sami ;
Pozdnyakov, Alex ;
Ramadan, Sherif ;
Chaudhari, Hanu ;
Young, J. Edward M. ;
Gupta, Michael ;
Harish, Srinivasan .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (02) :107-118
[2]  
CADY B, 1988, SURGERY, V104, P947
[3]   Should central lymph node dissection be considered for all papillary thyroid microcarcinoma? [J].
Chang, Young Woo ;
Kim, Hwan Soo ;
Kim, Hoon Yub ;
Lee, Jae Bok ;
Bae, Jeoung Won ;
Son, Gil Soo .
ASIAN JOURNAL OF SURGERY, 2016, 39 (04) :197-201
[4]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[5]   Lymph node surgery in papillary thyroid carcinoma [J].
Gemsenjäger, E ;
Perren, A ;
Seifert, B ;
Schüler, G ;
Schweizer, I ;
Heitz, PU .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (02) :182-190
[6]   Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study [J].
Gui, C. Y. ;
Qiu, S. L. ;
Peng, Z. H. ;
Wang, M. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (04) :403-409
[7]   Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence [J].
Hall, Chad M. ;
Snyder, Samuel K. ;
Maldonado, Yolanda Munoz ;
Lairmore, Terry C. .
SURGERY, 2016, 160 (04) :1049-1057
[8]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133
[9]  
HAY ID, 1993, SURGERY, V114, P1050
[10]   Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid [J].
Ito, Y ;
Tomoda, C ;
Uruno, T ;
Takamura, Y ;
Miya, A ;
Kobayashi, K ;
Matsuzuka, F ;
Kuma, K ;
Miyauchi, A .
WORLD JOURNAL OF SURGERY, 2006, 30 (01) :91-99